Prostate Cancer Survival Calculator According to Initial Treatment Modality
(based on the SCaP database)
Variables at prostate cancer diagnosis
Age
Height (cm)
Weight (kg)
PSA (ng/mL)
Prostate volume (cc)
Positive core number (out of 12)
Maximal core percentage
Gleason score
6
7(3+4)
7(4+3)
8(3+5)
8(4+4)
8(5+3)
9(4+5)
9(5+4)
10(5+5)
Unknown
Charlson Comorbidity Index
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
>16
Unknown
ECOG performance status
0
1
2
3
4
5
>6
Unknown
cT stage
T1a
T1b
T1c
T2a
T2b
T2c
T3a
T3b
T4
Unknown
cN stage
N1
N0
Unknown
cM stage
M1
M0
Unknown
Second primary malignancy
Yes
None or recurrence-free period >5 year
Hypertension
Yes
No
Unknown
Diabetes mellitus
Yes
No
Unknown
Tuberculosis
Yes
No
Unknown
Liver cirrhosis
Yes
No
Unknown
Cerebrovascular disease
Yes
No
Unknown
* This system is operated by a long short-term memory artificial neural network model based on survival data of 7,267 Korean prostate cancer patients diagnosed between 1988 and 2017; therefore, the results may not be applicable for certain individuals.
* Note that the survival estimates are based on the initial treatment modality. Actual survival may vary according to subsequent multidisciplinary treatments.
Results
5 year survivals
10 year survivals
5 year survivals
ADT
AS
RP
RTx
RTx+ADT
Progression to CRPC-free survival
%
-
-
-
%
Cancer-specific survival
%
%
%
%
%
Overall survival
%
%
%
%
%
10 year survivals
ADT
AS
RP
RTx
RTx+ADT
Progression to CRPC-free survival
%
-
-
-
%
Cancer-specific survival
%
%
%
%
%
Overall survival
%
%
%
%
%
Charts
Progression to CRPC-free survival
Cancer-specific survival
Overall survival
clear
Send E-mail
Send an email with a PDF file.
email